Research and Development

Showing 15 posts of 9573 posts found.

astrazeneca image

AstraZeneca reveals Alderley Park plan

May 8, 2013 Research and Development, Sales and Marketing AstraZeneca, BioCity, R&D, alderley

AstraZeneca has left a key question about what to do with its soon-to-be defunct R&D site in Cheshire in the …

Funding boost for GSK open lab

May 7, 2013 Research and Development, Sales and Marketing GSK, Wellcome

GlaxoSmithKline has been given an extra £5 million by the Wellcome Trust to help support its work in Spain on …
Buffet image

Lessons from the business gurus

May 7, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MSI, buffet, business gurus

Marketing books are full of pithy quotes from business gurus, quotes which are often repeated until they almost become mantras. …
28569_guenter_100

Sanofi appoints two executive members

May 3, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, executive

Sanofi has announced a new commercial organisation which results in the appointment of two executives. Following the retirement of Hanspeter …
Boehringer image

Boehringer and OBT in cancer tie-up

May 2, 2013 Research and Development, Sales and Marketing Boehringer, Cancer, OBT

Boehringer Ingelheim and UK biotech firm Oxford BioTherapeutics (OBT) have signed a deal to discover novel antibody targets in cancer. …
EMA image

Court rules against EMA disclosure

May 2, 2013 Medical Communications, Research and Development, Sales and Marketing AbbVie, EMA, Roche, transparency

The European Medicines Agency (EMA) has been ordered in an interim ruling by the General Court of the European Union …

GSK abandons Parkinson’s drug

May 1, 2013 Research and Development, Sales and Marketing GSK, IPX066, Parkinson's

GlaxoSmithKline has terminated its three-year old agreement with Impax Pharmaceuticals to develop investigational Parkinson’s disease drug IPX066. “The decision has …

Pfizer and Merck create major diabetes alliance

April 30, 2013 Research and Development, Sales and Marketing Merck, Pfizer, diabetes

Pfizer and Merck have unveiled a major new alliance in diabetes which is likely to raise the stakes in the …
hooper

Evolution Marketing Research hires senior director

April 30, 2013 Medical Communications, Research and Development, Sales and Marketing Evolution marketing research, david hooper

Healthcare marketing agency Evolution Marketing Research has appointed David Hooper to the firm as senior director, Research. Hooper brings more …
ctca_-gerard-van-grinsven-90-2-1367000496mr

CTCA changes leadership

April 29, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CTCA

The Cancer Treatment Centers of America (CTCA) network has made a change in its executive leadership with the appointment of  …
Merck image

Melanoma breakthrough for Merck

April 26, 2013 Research and Development, Sales and Marketing FDA, Merck, lambrolizumab, melanoma

Merck’s pipeline has been given a boost by an FDA decision to designate early-stage investigational drug lambrolizumab as a breakthrough …

Pharma R&D ‘untenable’

April 25, 2013 Research and Development, Sales and Marketing GlobalData, R&D

The current model by which pharma carries out R&D is ‘untenable’, according to a new report. But the research, from …

Boehringer’s online PMCPA breach

April 25, 2013 Medical Communications, Research and Development, Sales and Marketing ABPI, AF, Boehringer, PMCPA

Boehringer Ingelheim has failed to uphold high standards, according to the PMCPA, which enforces the ABPI Code of Practice, over …

Navigating Cancer hires VP from InVentiv Health

April 25, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing inVentic Health, navigating cancer

Cancer support service company Navigating Cancer has appointed Suzanne Greenwood to the firm as vice president, Bio-Pharmaceutical Services. Greenwood has …

£50m oncology fund pays out

April 24, 2013 Research and Development, Sales and Marketing Cancer, ICR, MPS1

The Institute of Cancer Research (ICR) in London has become the first recipient of money from a £50 million fund …
The Gateway to Local Adoption Series

Latest content